Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Surwit

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|February 15, 1994
Comparative exposure ratios: a non-parametric, multifactor technique for case-control studiesM Aickin, C Ritenbaugh, E Surwit, et al.
American Journal of Clinical Oncology|December 1, 1983
Treatment of locally advanced cancer of the cervix with transperineal interstitial irradiation. Report on 106 casesS A Aristizabal, E Surwit, A Valencia, et al.
Arizona Medicine|August 1, 1981
Invasive carcinoma of the cervix treated primarily with radiation therapy: University of Arizona experienceS A Aristizabal, R J Giever, A Duque, et al.
Obstetrics and Gynecology|August 1, 1976
Radical hysterectomy with or without preoperative radium for stage IB squamous cell carcinoma of the cervixE Surwit, W C Fowler, L Palumbo, et al.
Oncology|November 1, 1993
Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancerE V Hannigan, S Green, D S Alberts, et al.
Cancer Treatment Reviews|September 1, 1985
Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group studyD Alberts, N Mason, E Surwit, et al.
Cancer Treatment Reports|February 1, 1984
Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group studyR D Hilgers, S S Legha, J G Boutselis, et al.
Journal of the National Cancer Institute|April 6, 1994
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trialF L Meyskens, E Surwit, T E Moon, et al.
American Journal of Clinical Oncology|February 1, 1994
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group studyV K Malviya, P Y Liu, R O'Toole, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|February 15, 1994
Comparative exposure ratios: a non-parametric, multifactor technique for case-control studiesM Aickin, C Ritenbaugh, E Surwit, et al.
American Journal of Clinical Oncology|December 1, 1983
Treatment of locally advanced cancer of the cervix with transperineal interstitial irradiation. Report on 106 casesS A Aristizabal, E Surwit, A Valencia, et al.
Arizona Medicine|August 1, 1981
Invasive carcinoma of the cervix treated primarily with radiation therapy: University of Arizona experienceS A Aristizabal, R J Giever, A Duque, et al.
Obstetrics and Gynecology|August 1, 1976
Radical hysterectomy with or without preoperative radium for stage IB squamous cell carcinoma of the cervixE Surwit, W C Fowler, L Palumbo, et al.
Oncology|November 1, 1993
Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancerE V Hannigan, S Green, D S Alberts, et al.
Cancer Treatment Reviews|September 1, 1985
Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group studyD Alberts, N Mason, E Surwit, et al.
Cancer Treatment Reports|February 1, 1984
Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group studyR D Hilgers, S S Legha, J G Boutselis, et al.
Journal of the National Cancer Institute|April 6, 1994
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trialF L Meyskens, E Surwit, T E Moon, et al.
American Journal of Clinical Oncology|February 1, 1994
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group studyV K Malviya, P Y Liu, R O'Toole, et al.
Pageof 1